TherapeuticsMD, Inc. (TXMD)
NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 21.57M |
| Enterprise value | 25.24M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.00 |
| Price/book (mrq) | 0.74 |
| Enterprise value/revenue | 19.39 |
| Enterprise value/EBITDA | -3.32 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.04 |
| 52-week change 3 | -47.18% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 4.7200 |
| 52-week low 3 | 1.8600 |
| 50-day moving average 3 | 2.2264 |
| 200-day moving average 3 | 2.7308 |
Share statistics
| Avg vol (3-month) 3 | 22.51k |
| Avg vol (10-day) 3 | 22.59k |
| Shares outstanding 5 | 11.53M |
| Implied shares outstanding 6 | 11.84M |
| Float 8 | 9.91M |
| % held by insiders 1 | 3.78% |
| % held by institutions 1 | 28.20% |
| Shares short (15 Apr 2024) 4 | 45.91k |
| Short ratio (15 Apr 2024) 4 | 1.63 |
| Short % of float (15 Apr 2024) 4 | 0.48% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.40% |
| Shares short (prior month 15 Mar 2024) 4 | 47.38k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:50 |
| Last split date 3 | 09 May 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -320.92% |
Management effectiveness
| Return on assets (ttm) | -7.96% |
| Return on equity (ttm) | -23.90% |
Income statement
| Revenue (ttm) | 1.3M |
| Revenue per share (ttm) | 0.12 |
| Quarterly revenue growth (yoy) | -99.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -8.4M |
| Net income avi to common (ttm) | -7.7M |
| Diluted EPS (ttm) | -0.7400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.33M |
| Total cash per share (mrq) | 0.38 |
| Total debt (mrq) | 8.01M |
| Total debt/equity (mrq) | 27.33% |
| Current ratio (mrq) | 1.72 |
| Book value per share (mrq) | 2.54 |
Cash flow statement
| Operating cash flow (ttm) | -48.14M |
| Levered free cash flow (ttm) | -34.19M |
© 2024 Yahoo. All rights reserved.